Search research articles
Contact Us
Filters
Showing results (21-30 of 148) with videos related to
Page
of 15
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 10, 2005
Dose to bone marrow using IMRT techniques in prostate cancer patients
Eduard Gershkevitsh, Catharine H Clark, John Staffurth, et al.
BJU International
|
June 1, 2007
Long-term effects of a short course of neoadjuvant luteinizing hormone-releasing hormone analogue and radical radiotherapy on the hormonal profile in patients with localized prostate cancer
Vedang Murthy, Andrew R Norman, Yolanda Barbachano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 20, 2009
Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397)
Isabel Syndikus, Rachel C Morgan, Matthew R Sydes, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 30, 2017
Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397)
Agnieszka Lemanska, Tao Chen, David P Dearnaley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 7, 2004
Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate
Sarah L Gulliford, Steve Webb, Carl G Rowbottom, et al.
BJU International
|
December 13, 2006
The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)
Richard J Stephens, David P Dearnaley, Richard Cowan, et al.
BJU International
|
June 8, 2007
The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours
Ramachandran Venkitaraman, Bernadette Johnson, Robert A Huddart, et al.
Physics in Medicine and Biology
|
October 15, 2009
Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397)
Florian Buettner, Sarah L Gulliford, Steve Webb, et al.
The Lancet. Oncology
|
August 14, 2009
Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
David P Dearnaley, Malcolm D Mason, Mahesh K B Parmar, et al.
BJU International
|
October 19, 2007
Efficacy of low-dose dexamethasone in castration-refractory prostate cancer
Ramachandran Venkitaraman, Karen Thomas, Robert A Huddart, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 148) with videos related to
Sort By:
Page
of 15
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 10, 2005
Dose to bone marrow using IMRT techniques in prostate cancer patients
Eduard Gershkevitsh, Catharine H Clark, John Staffurth, et al.
BJU International
|
June 1, 2007
Long-term effects of a short course of neoadjuvant luteinizing hormone-releasing hormone analogue and radical radiotherapy on the hormonal profile in patients with localized prostate cancer
Vedang Murthy, Andrew R Norman, Yolanda Barbachano, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 20, 2009
Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397)
Isabel Syndikus, Rachel C Morgan, Matthew R Sydes, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 30, 2017
Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397)
Agnieszka Lemanska, Tao Chen, David P Dearnaley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 7, 2004
Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate
Sarah L Gulliford, Steve Webb, Carl G Rowbottom, et al.
BJU International
|
December 13, 2006
The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)
Richard J Stephens, David P Dearnaley, Richard Cowan, et al.
BJU International
|
June 8, 2007
The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours
Ramachandran Venkitaraman, Bernadette Johnson, Robert A Huddart, et al.
Physics in Medicine and Biology
|
October 15, 2009
Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397)
Florian Buettner, Sarah L Gulliford, Steve Webb, et al.
The Lancet. Oncology
|
August 14, 2009
Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
David P Dearnaley, Malcolm D Mason, Mahesh K B Parmar, et al.
BJU International
|
October 19, 2007
Efficacy of low-dose dexamethasone in castration-refractory prostate cancer
Ramachandran Venkitaraman, Karen Thomas, Robert A Huddart, et al.
Page
of 15